Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Salim S. Hayek, Eva L. Feldman et al.|Diabetes Care|2022Cited by 74
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosisGeorge Hindy, Salim S. Hayek, Susan R. Heckbert et al.|Journal of Clinical Investigation|2022Cited by 70
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19Shengyuan Luo, Yiyuan Huang, Kim A. Williams et al.|Journal of the American Heart Association|2022Cited by 16
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19Alexi Vasbinder, Evangelos J. Giamarellos‐Bourboulis, Tariq U. Azam et al.|Journal of Medical Virology|2024Cited by 14